Navigation Links
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke

in improving carotid stenting outcomes," said Chuck Foltz, vice president, Abbott Vascular. "We are proud of our leadership in carotid stenting trials, with more than 10,000 patients enrolled in Abbott trials in the United States. These studies demonstrate that carotid stenting is making a difference in the lives of patients."

New Study Evaluates Next-Generation Embolic Protection Device

Abbott's next-generation Emboshield PRO(TM) Embolic Protection System, currently available in Europe, is under safety and effectiveness evaluation in PROTECT, a new U.S. clinical trial which recently began enrolling patients. The study will include 320 high surgical risk patients at 50 U.S. clinical sites. Patients will be evaluated at 30 days following stent placement to gather safety and efficacy data to support a 510(k) application to the U.S. Food and Drug Administration (FDA) for Emboshield PRO.

About Carotid Artery Disease and Stroke

Stroke is the third leading cause of death in the United States and the number one cause of disability in adults, according to the American Heart Association. Approximately 25 percent of strokes are caused by carotid artery disease. Clogged carotid arteries in the neck can cause ischemic stroke, the most common type. More than 700,000 Americans will have new (500,000) or recurrent (200,000) strokes each year, and more than 150,000 will die.

About Carotid Stenting

Carotid artery stenting is a minimally invasive treatment option for patients who require intervention and who are at high risk for complications from carotid endarterectomy, an invasive surgical procedure. Carotid artery stenting is performed by delivering a stent on a catheter through the femoral artery in the groin. The catheter is maneuvered through the patient's vasculature to the carotid artery. The stent, which is designed to prevent arterial plaque and debris from breaking off and blocking blood flow to the brain, is then expanded at the
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:10/2/2014)... 2, 2014  MJ Freeway®, the industry-leading cannabis business ... detailing upcoming legalization efforts in Oregon ... Nevada .  The success of the measures being ... on the national level. On October 7th, ... the Marijuana Policy Project, an organization dedicated to making ...
(Date:10/2/2014)... , Oct. 2, 2014  Isis Pharmaceuticals, Inc. ... webcast:What: , Webcast and conference call to provide ... clinical studies of ISIS-SMN Rx in infants ... will be presented on the morning (CEST) of ... Muscle Society in Berlin, GermanyWhen:Friday, October 10 at ...
(Date:10/1/2014)... Calif. , Oct. 1, 2014  Abaxis, Inc. ... manufacturing point-of-care instruments and consumables for the medical, research, ... to the veterinary and research markets in ... entered into a definitive distribution agreement with Patterson Veterinary ... and promote the full line of Abaxis veterinary products ...
Breaking Medicine Technology:MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
(Date:10/2/2014)... 02, 2014 Originally considered alternative ... is becoming increasingly popular with consumers. This has ... Poultry Farming industry in Australia. According to ... organic meat has surged over the past five ... the farming level.” Over the five years through ...
(Date:10/2/2014)... (HealthDay News) -- Scientists have pinpointed a molecule that ... colds. The researchers say this finding could offer ... treat these attacks. Most asthma attacks (80 percent ... the airways, according to the British researchers. Most of ... the common cold. The researchers found that a ...
(Date:10/2/2014)... Dennis Thompson HealthDay ... A newborn,s risk of developing celiac disease isn,t reduced by ... in wheat called gluten to an infant,s diet help prevent ... pair of new studies in the Oct. 2 New ... to rest hopes that a child could avoid celiac disease ...
(Date:10/2/2014)... University of Nottingham could lead to the development of ... resulting from the research, published in the journal ... sufferers of chronic pain conditions such as traumatic nerve ... , The work, led by Dr Lucy Donaldson in ... David Bates, Professor of Oncology in the University,s Cancer ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
Breaking Medicine News(10 mins):Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Livestock and Poultry Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:Medical discovery first step on path to new painkillers 2Health News:Study finds acupuncture does not improve chronic knee pain 2
... 29 LodgeNet Interactive Corporation (Nasdaq: LNET ... offering of 50,000 shares of 10% Series B Cumulative ... liquidation preference of $1,000 per share. In addition, the ... to purchase an additional 7,500 shares of preferred stock ...
... HealthCare System has organized a new business unit ... North and South Carolina. , , The newly ... (SHVI) represents a combination of Sanger Clinic, Charlotte Cardiology Associates ... serving as a regional referral center for highly specialized care. ...
... Clovis Students Win Thousands of Dollars in Milk Contest , ... month after month with Premenstrual Syndrome, a.k.a. man,s worst nightmare. ... whom do not yet know that milk could be the ... effort to educate women on the PMS-fighting benefits of the ...
... ... to share their perspectives on eye care and safety. , ... Minneapolis, MN (PRWEB) June 29, 2009 -- Stop squinting…proper eye ... July,s fireworks displays in all their brilliance and clarity., , , The Healthcare Scoop , ...
... , JACKSONVILLE, Fla., June 29 On June ... the European Association for the Study of Diabetes investigated ... sanofi-aventis) and the development of certain malignancies. The authors ... their limited data and analyses, which precluded them from ...
... most parents of high school and college-age students and they,ll tell ... life,s tough questions. Truth is, at that age they are forming ... their lives. A new initiative, Reach Teach Learn , is ... that honest, educated decisions are made. , , Alpharma Inc., ...
Cached Medicine News:Health News:LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock 2Health News:LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock 3Health News:LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock 4Health News:Sanger Clinic Lends Its Name to New Heart Care Institute Serving NC and SC 2Health News:No More Drama With TOMA LECHE 2Health News:No More Drama With TOMA LECHE 3Health News:No More Drama With TOMA LECHE 4Health News:The Healthcare Scoop Community Says 'Eye Care' 2Health News:The Healthcare Scoop Community Says 'Eye Care' 3Health News:AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia 2Health News:Alpharma's Reach Teach Learn Initiative Targets Youth and Consumer Awareness 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: